We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.25T
AUM Growth
-$1.02T
Cap. Flow
-$1.16T
Cap. Flow %
-93.16%
Top 10 Hldgs %
19.22%
Holding
8,154
New
333
Increased
458
Reduced
6,748
Closed
331

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.9B
2
AAPL icon
Apple
AAPL
+$38.9B
3
AMZN icon
Amazon
AMZN
+$26B
4
NVDA icon
NVIDIA
NVDA
+$23.3B
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17B

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 10.81%
3 Healthcare 9.76%
4 Consumer Discretionary 9.08%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCX
5251
DELISTED
The L.S. Starrett Company
SCX
$412K ﹤0.01%
25,926
-762,844
-97% -$9.85M
MPTI icon
5252
M-tron Industries
MPTI
$377M
$405K ﹤0.01%
13,495
-7,683
-36% -$289K
CLVT.PRA
5253
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
$402K ﹤0.01%
13,442
-3,414
-20% -$116K
CRT
5254
Cross Timbers Royalty Trust
CRT
$61M
$402K ﹤0.01%
30,793
-3,773
-11% -$63.5K
LYRA
5255
DELISTED
LYRA THERAPEUTICS INC
LYRA
$401K ﹤0.01%
+1,288
New +$343K
UFOX
5256
Defiance Space and Connective Tech ETF
UFOX
$888M
$399K ﹤0.01%
10,204
-9,384
-48% -$352K
GENC icon
5257
Gencor Industries
GENC
$212M
$398K ﹤0.01%
23,823
-17,637
-43% -$284K
WMPN
5258
DELISTED
William Penn Bancorporation Common Stock
WMPN
$397K ﹤0.01%
32,164
-5,464
-15% -$66.8K
BUFR icon
5259
FT Vest Fund of Buffer ETFs
BUFR
$10.3B
$397K ﹤0.01%
14,192
-11,472
-45% -$313K
NOTV
5260
DELISTED
Inotiv
NOTV
$397K ﹤0.01%
36,269
+30,233
+501% +$181K
AQST icon
5261
Aquestive Therapeutics
AQST
$471M
$396K ﹤0.01%
92,922
+44,592
+92% +$148K
SKYT
5262
DELISTED
SkyWater Technology
SKYT
$394K ﹤0.01%
38,782
-87,540
-69% -$862K
GLUE icon
5263
Monte Rosa Therapeutics
GLUE
$1.32B
$393K ﹤0.01%
55,730
-107,222
-66% -$636K
STRS icon
5264
Stratus Properties
STRS
$159M
$392K ﹤0.01%
17,172
-23,298
-58% -$547K
WNEB icon
5265
Western New England Bancorp
WNEB
$281M
$392K ﹤0.01%
51,111
-40,291
-44% -$335K
NL icon
5266
NLI Holdings
NL
$281M
$392K ﹤0.01%
53,478
-63,724
-54% -$359K
PDN icon
5267
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$362M
$389K ﹤0.01%
11,823
-11,407
-49% -$365K
IGIC icon
5268
International General Insurance
IGIC
$1.15B
$387K ﹤0.01%
28,617
-28,443
-50% -$370K
INVZ icon
5269
Innoviz Technologies
INVZ
$88.8M
$387K ﹤0.01%
286,556
-333,718
-54% -$560K
BNRE.A
5270
DELISTED
Brookfield Reinsurance Ltd. Class A-1 Exchangeable Non-Voting Shares
BNRE.A
$387K ﹤0.01%
9,302
-19,302
-67% -$782K
UMI icon
5271
USCF Midstream Energy Income Fund
UMI
$496M
$386K ﹤0.01%
9,573
-8,707
-48% -$327K
VTNR
5272
DELISTED
Vertex Energy, Inc
VTNR
$386K ﹤0.01%
275,576
-367,410
-57% -$586K
PHDG icon
5273
Invesco S&P 500 Downside Hedged ETF
PHDG
$64.9M
$386K ﹤0.01%
10,487
-11,373
-52% -$403K
MURA
5274
DELISTED
Mural Oncology
MURA
$385K ﹤0.01%
78,753
-142,613
-64% -$692K
FDBC icon
5275
Fidelity D&D Bancorp
FDBC
$313M
$382K ﹤0.01%
7,885
-13,721
-64% -$675K

Similar funds

Morgan Stanley's Q1 2024 Portfolio in Review

As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.

  • Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
  • Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
  • Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
  • Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
  • Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
  • Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
  • Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.